Clonal rearrangements of the Ig heavy chain (/GM locus OCcur in nearly all cases of B-cell precursor acute leukemia (BCP-ALL). Some of these rearrangements may be detected by polymerase chain reaction (PCR) using VH gene framework 111 (FRIII) and J H consensus primers. However, about 20% of BCP-ALLs fail t o amplify with this technique. To determine the causes of these PCR failures and t o investigate any possible association with specific subgroups of disease, we analyzed 72 acute leukemias of defined immunophenotype and cytogenetics, comparing FRlll with VH-family leader-specific PCR methods and Southern blotting. Of 37 BCP-ALL cases, 6 (16.296) failed totally t o amplify with FRlll and J H primers. None of these cases amplified with VH leader primers. Additionally, all cases retained germline VH6 genes and 5 of 11 rearranged alleles amplified with a consensus DH primer, indicating that these rearrangements represented biallelic DHJH recombinations. Among the 6 FRlll and VH leader PCR-negative BCP-ALL cases, there was no common immunophenotype or consistent cytogenetic abnormality, although all showed structural chromosomal abnormalities and 3 of 5 successfully karyotyped had abnormalities of chromosome 12p. 13 cases with t(9;22)(q34;qll) (Philadelphia chromosome-positive [Ph'l) and IGH rearrangements (9 BCP-ALL and 4 biphenotypic cases) were also analyzed. Of 23 rearranged IGH alleles, 19 (82%) were positive by FRlll HE HUMAN IG HEAVY-CHAIN locus (IGH) lies adjacent to the telomere of the long arm of chromosome 14 at 14q32.3. The locus consists of dispersed gene segments (51 functional VH genes, at least 30 pseudogenes, some 30 to 50 DH segments, and 6 JH segments) that must undergo somatic recombination to produce functional Ig molecules."' Somatic recombination occurs very early in B-cell ontogeny and has been shown to be developmentally reg~lated.4.~ In particular, DH-JH recombination precedes VH-DH recombinatiom6 Furthermore, although not necessary for the early stages of B-cell differentiation, functional Ig molecules resulting from productively rearranged IGH genes are necessary for the continued survival of B-cell precursors (BCPs) that otherwise undergo apoptosis within the bone marrow, which is the fate of most BCPS.'.~ Clonal IGH rearrangements may be detected in virtually all B-cell-lineage malignancies.' The combinatorial diver- The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact. 0 1996 by The American Society of Hematology. 0006-4971/96/8712-0037$3.00/0 5242 PCR, and all 4 remaining alleles were amplified by VH leader primers. Use of the leader primers in these Ph+ cases also detected 3 additional clonal rearrangements that were not anticipated from Southern blotting; such unexpected bands were not observed in 21 other Ph-cases. The additional bands represented "new" and unrelated VH rearrangements rather than VH-VH replacement events. We conclude that biallelic DHJH rearrangements occur in a subgroup of BCP-ALL; in these cases, the activation of the full VHDHJH recombination mechanism had not occurred. Therefore, these cases of BCP-ALL were arrested at an early stage of B-cell differentiation. In contrast, all Ph+ BCP-ALLs and biphenotypic acute leukemias, which may represent the transformation of multipotent hemopoietic stem cells, had undergone VHDHJH recombination. Of 9 Ph+ BCP-ALL cases, 3 also showed ongoing VHDHJH rearrangement, reflecting the persistent expression of the VHDHJH recombinase. Finally, sequence analysis of 33 rearranged VHDHJH genes showed that only 3 including 2 Ph' BCP-ALL maintained an intact open-reading frame.
PCR, and all 4 remaining alleles were amplified by VH leader primers. Use of the leader primers in these Ph+ cases also detected 3 additional clonal rearrangements that were not anticipated from Southern blotting; such unexpected bands were not observed in 21 other Ph-cases. The additional bands represented "new" and unrelated VH rearrangements rather than VH-VH replacement events. We conclude that biallelic DHJH rearrangements occur in a subgroup of BCP-ALL; in these cases, the activation of the full VHDHJH recombination mechanism had not occurred. Therefore, these cases of BCP-ALL were arrested at an early stage of B-cell differentiation. In contrast, all Ph+ BCP-ALLs and biphenotypic acute leukemias, which may represent the transformation of multipotent hemopoietic stem cells, had undergone VHDHJH recombination. Of 9 Ph+ BCP-ALL cases, 3 also showed ongoing VHDHJH rearrangement, reflecting the persistent expression of the VHDHJH recombinase. Finally, sequence analysis of 33 rearranged VHDHJH genes showed that only 3 including 2 Ph' BCP-ALL maintained an intact open-reading frame.
Loss of the open-reading frame occurred not only because of out-of-frame VHDH and DHJH joining, but also because of VH gene mutation and deletion. These data show that most BCP-ALLs may represent the neoplastic transformation of BCPs destined t o die in the bone marrow. 0 1996 b y The American Society of Hematology.
sity arising from the apparently random assortment of VH, DH, and J H segments, along with the insertion of both N and P nucleotides at the time of recombination, results in each VHDHJH junction being unique.'" Therefore, the VHDHJH sequence provides a good clonal marker. Several polymerase chain reaction (PCR) methods have been designed to amplify VHDHJH junctions and have been widely used to detect minimal residual disease, particularly in the context of BCPacute lymphoblastic leukemia (BCP-ALL).""' The most commonly used method involves primers to a conserved region of the framework 111 (FRIII) region of the VH gene segments and a consensus JH primer that amplifies the third complementarity-determining region (CDRIII)." Although readily performed, limitations of the method are (1) that only a proportion of rearranged IGH alleles are amplifiable and (2) that up to 30% of BCP-ALL cases may be completely negative." Lack of CDRIII amplification may reflect loss of the FRIII primer sequence because of VH pseudogene usage, VH gene deletion arising from "nibbling" at the time of recombination, DH-JH rearrangement, or rarely in BCP-ALL, chromosomal translocation to the IGH locus.'' Alternatively, loss of the JH primer sequence may arise because of JH deletion that may occasionally be biallelic.IR Because VHDHJH recombination is normally a developmentally regulated process, the identification of FRIIVJH PCR-negative cases of BCP-ALL resulting from arrested DHJH recombination might be of clinical significance in that these cases may represent BCPs arrested at a very early stage of differentiation, before the activation of the VH-DH recombinase. Therefore, we sought to determine the causes For personal use only. on September 24, 2017. by guest www.bloodjournal.org From ting using a J H probe with those of PCR using FRIIVJH and V,., leader-specific/JH primer combinations.
MATERIALS AND METHODS

Clinical and Diagnostic Data
A total of 72 cases of acute leukemia were classified following morphological, immunophenotypic, and cytogenetic analysis. The immunophenotyping was performed with a panel of monoclonal antibodies, and a scoring system was adopted to identify biphenotypic case^.'^.^^ The cases were initially classified as follows: 41 BCP-ALL; 12 T-cell precursor-ALL (TCP-ALL); and 19 acute myeloid leukemia (M) . Using this system, 4 cases of BCP-ALL were considered to be biphenotypic by coexpression of multiple myeloid markers. Similarly, 2 cases of AML were considered to be biphenotypic by coexpression of multiple lymphoid markers. Details of initial clinical and diagnostic data of the cases of BCP-ALL are shown in Table 1 .
Amongst the BCP-ALL cases (no. I through 41), there were 17 adults and 24 children (aged <15; age range, 2 to 70 years; mean age, 16.6 years). Cytogenetic analysis identified 19 translocations; 12 cases had t(9;22) or variant translocations and 1 had t(8; 14)(q24;q32). Five hyperdiploid cases were identified; however, additional copies of chromosome 14 were only identified in 1 case.
Three of the four biphenotypic cases had t(9;22), the fourth was bcr-abl negative as determined by reverse transcription-PCR (F. van Rhee, personal communication, May 1994).
TCP-ALL cases consisted of 9 adults and 3 children (age range, 4 to 27 years; mean age, 18.6 years). Cytogenetic analysis identified two translocations; one t(1 l; 14)(p13;qll) and one t(9;22)(q34;ql l).
Clones were detected in 4 other cases. No cases were considered to be biphenotypic.
AML cases consisted of 17 adults and 2 children (age range, 3 to 60 years; mean age, 33 years). Cytogenetic analysis identified nine translocations including 2 with t(9;22)(q34;qll), and clones were identified in an additional 5 cases. Two biphenotypic cases were identified, both with t(9; 22)(q34; ql1).
In several cases, material obtained at diagnosis was also passaged in SCID mice:' and DNA was extracted from serial passages for comparative analysis by Southern blot and PCR as described below.
DNA Blotting
High molecular weight DNA was extracted from a mononuclear fraction of either bone mmow or peripheral blood by conventional methods. High molecular weight DNA (15 pg) was digested for 3 to 4 hours at 37°C with restriction enzymes BglII, EcoRI, HindIII, and BarnHI. Southern blotting was performed as described.'* Hybridization to a JH probe (clone C76R51A)" and, in selected cases, to a TCRD probe JdS1623 and a CDKN2 probe" was performed. A VH6 gene probe kindly provided by Dr P.W. Tucker (Southwestern University, Dallas TX)" was used to probe cases with apparent biallelic DHJH rearrangement.
PCR
The following are the sequences of the primers used in this study. The FRI PCR sequences were as follows: VH1 FRI, 5"CCTCAGT-GACTCTGCTGTGCA-3'13 in combination with the JH consensus primer.
DH PCR. The choice of DH primer was based on the fact that the DHL,X families and the DHpsz segments are the most commonly used in BCP-ALL and TCP-ALL, respectivelyz5."; therefore, the primer was designed to the spacerheptamer sequence 5' of the DHL, X, Q families. However, if other DH segments were used, these would not be detected. If the PCR had amplified germJine DNA, the smallest product obtained would have been 152 bp (the distance between DHQS2 and JH1). All PCR products were smaller than this, which precluded contamination with residual normal cells. The sequences used were as follows: DH primer, 5'-(GR)(GR)G(G/ A)GG(T/C)(T/C) TGT GTC ACT GTG-3'; J,1456 primer, 5'-ACC-TGAGGAGACGGTGACC-3'; JH2 primer, 5'-GCTGGACAGA-GAAGACTGGGA-3'; and JH3 primer, 5'-AGCTCCAGGACA-PCR to check DNA integrity. Primers from the acetyl coA acetyltransferase gene were used to check the integrity of the DNA; the sequences were as follows: 5'-GACGGGCTAACT-GATGTCTAC-3' and 5'-ATTAGCCAAGCAGTTGCCAGC-3'. All DNA samples used in this study were amplifiable with this primer combination. was performed in a Biometra TRIOthermoblock (Gottingen, Germany). Denaturation for all reactions was at 93°C initially for 3 minutes and during 30 subsequent cycles for 20 seconds. Annealing temperatures were as follows: for FRIIUJH consensus PCR, FRI vH1, and 3/JH PCR, VH3, 4, and 6 leader/J, consensus PCR, and acetyl coA acetyl transferase PCR, 55°C; for vH1 leader/JH consensus PCR, 56°C; for VH2 leader/JH consensus PCR, 58°C; for vH5 leader/J, consensus PCR, 59°C; for D~/ J~1 4 5 6 PCR, 50°C; and for DH/JH2 PCR and A11 annealing and elongation reactions were performed for 20 seconds and 30 seconds, respectively, for 30 cycles, and the final elongation step was performed at 72°C for 5 minutes. Appropriate positive and negative controls were included, and each PCR was performed on at least two separate occasions. Aliquots of the reactions were analyzed by electrophoresis in 3% agarose and 8% nondenaturing polyacrylamide (FRIIVJH consensus) or 10% nondenaturing polyacrylamide (DH/JH PCR) or 1.2% agarose gel (V, leader/JH consensus PCR) or 1.5% agarose gel (acetyl coA acetyltransferase PCR); the aliquots were then stained with ethidium bromide and visualized under UV light. Products of the FRIIVJH PCR and VH leader/J, PCR reactions were ligated into pGEM-T vector (Promega), XL1-Blue cells were transformed, and 3 to 7 white colonies were picked. Double-stranded sequencing was performed in both directions using the dideoxychain termination method with the 'l7 and SP6 primers using Taq DNA polymerase (Taquence 2.0; US Biochemicals, Cleveland, OH). case "g" or "r" represents weak band.
Cloning and Sequencing of PCR Products
arranged IGH alleles on DNA blot completely failed to amplify with FRIII PCR. Furthermore, a total of 25 of 78 (32%) rearranged alleles observed on Southern blot failed to amplify by this method. To investigate the apparent failure of FRIII PCR, further experiments were performed, initially, using the VH leader family primers with the JH consensus primer and, subsequently, using a DH primer with JH-specific primers in cases that remained persistently VH PCR-negative. The results have been analyzed according to different subgroups; (1) the 9 FRIII-negative cases, (2) the 14 Philadelphia chromosome-positive (Ph+) cases, and (3) cases with discrepancies between the DNA blot and FRIII PCR results.
FRIZZ-Negative Cases
A total of 9 cases (6 BCP-ALL and 3 TCP-ALL) with IGH rearrangements by DNA blot failed to amplify with the FRIII PCR. All 9 cases also failed to amplify with all the V H leader primers. In the absence of cytogenetically demonstrable translocations involving the IGH locus at 14q32.3 in 6 of the 9 cases, these data strongly suggested biallelic DH-J H rearrangement. Such DH-J H rearrangements were confirmed first by the use of a VH6-specific probe on Southern blot; all cases showed retention of this gene, confirming the lack of more distal VH rearrangement that would result in vH6 deletion. Second, PCR with a consensus DH primer that should amplify the most commonly used DH segments was performed. The results of analysis with DH PCR are shown in Table 2 . DH PCR products were obtained in 6 of 9 cases representing 7 of 15 rearranged IGH alleles. DH-JH rearrangements have been previously reported as a recurrent rearrangement in TCP-ALL with IGH rearra~~gernent.~' Therefore, further analysis focused on the 6 cases of BCP-ALL.
There were no consistent cytogenetic or immunophenotypic features in this group. However, all 5 cases that were successfully karyotyped showed structural abnormalities, and 3 had abnormalities of chromosome 12p. CD34 was positive in 3 and negative in 2 cases analyzed. Analysis of the TCRD rearrangements was performed in 4 cases and showed germline configuration in 2 and incomplete V2D3 rearrangements (the configuration associated with BCP-ALL)28 in 2, 1 of which was associated with deletion of the other allele and the other which occurred in combination with an incomplete TCRD D2J1 rearrangement. All cases retained both alleles of CDKNZ in germline config~ration.'~
Ph+ Cases
Of 72 cases, 14 were Ph+; these included 9 BCP-ALL, 1 TCP-ALL, and 5 biphenotypic cases. Excluding the case of Ph+ TCP-ALL that has been discussed above ( Table 2 , case no. 43), this group showed a total of 23 rearranged alleles by Southern blot; of these, 19 (76%) were amplified by FRIII PCR. Of the remaining 4 alleles, all 4 amplified with the VH leader primers. An unexpected finding was the detection of 2 and 1 additional clonal rearrangements in 2 cases of BCP-ALL (cases no. 23 and 39, respectively). In addition, PCR on SCID mouse passage material from a further BCP-ALL (case no. 33) also led to the identification of 2 new rearrangements (33 c and d) in addition to those present in the diagnostic material (33 a and b). Cloning and sequencing did not show any evidence of a clonal relationship, eg, VH-VH replacement or open-and-shut m e~h a n i s m ,~~*~~ between the different clones in these 3 cases that appeared to be totally unrelated (Fig 1) . In contrast, analysis of 21 Ph-BCP-ALL cases did not lead to the detection of any additional unexpected rearrangements. identified a total of 14 patients with BCP-ALL in whom there was a discrepancy between the number of rearranged alleles detected by the two methods. In all cases, fewer rearranged alleles were detected by FRIII PCR than were predicted by Southem blotting. In total, 16 of 29 rearranged alleles were detected by FRIII PCR in these cases. Table 3 shows the correlation of the two series of results.
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To determine the possible causes of failure of FFUI PCR, VH leader PCR was performed and the products cloned and sequenced. A total of 13 BCP-ALL cases with concordant DNA blot and FRIII PCR results were also studied in parallel. PCR using the VH leader primers led to the detection of a higher proportion of rearranged alleles in these cases (26 of 29 [90%]). In 9 of 14 cases, VH leader PCR identified the corresponding number of products predicted by Southern blot, and, by cloning and sequencing the products, it was possible to identify the reasons for the failure of FRIJI PCR in these cases. However, in 4 of 14 cases, fewer rearranged alleles were amplified than expected; these included cases no. 9, 16,20, and 22 in which only one product was obtained although two rearrangements were known to be present from the DNA blot data. However, one allele in case no. 20 would not be expected to amplify because of its involvement in the t(8;14)(q24;q32). In 1 of 14 cases (case no. 39), more rearrangements were detected by VH leader PCR than were predicted from DNA blot.
Sequencing of the products of the VH leader PCR in cases with discrepancies showed deletion of between 3 and 18 bases from the 3' end of the FRIII primer site. In 9 other cases, mutations within the primer site were also identified, but these did not affect the FRIII PCR. Sequencing of the cases with concordance between DNA blot and FRIII PCR showed intact FRIII primer sites.
Gene Segment Usage in BCP-ALL
Analysis of 33 sequenced rearranged VHDHJH products (Table 4) showed a bias in the VH segment usage. The vH3 family accounted for 15 of the sequences, 3 of which had homology with VH3-23, 2 with VH3-22 (and shared the same base-pair mismatches at the 3' end) and 2 with VH 3-7. Within the 8 vH1 family products, VH 1-18 was represented three times, and, of the 8 V& sequences, 3 shared homology Of note was the position of some of the VH segments in relation to J H in the germline; it has been suggested that developmental mechanisms operate in the generation of with VH 4-34 and 2 with VH 4-31. For personal use only. on September 24, 2017. by guest www.bloodjournal.org From mismatch from the germline sequence; case no. 24 [clg'/slg-CD10' biphenotypic leukemia with t(9;22)(q34;qll)l that showed a VH~-16 gene with 9.7% mismatch from the germline, and case no. 39 (a pre-6-cell, [CD19+/CD10~16CP-ALLwhich coexpressed myeloid antigens) that showed a VH3-7 gene with 1.3% mismatch from the germline. All other sequences showed mutations, insertions, or deletions within the V" genes resulting in loss of the ORF. There was no obvious difference in frequency of VH mutation according to VH gene family.
VHDHJH rearrangements in BCP-ALL, leading to preferential utilization of the gene segments closest to J H .~~*~~ However, in this study, only 4 of 33 rearrangements used VH gene segments less than 200 kb from J H ; 6 rearrangements used gene segments from the distal, telomeric region of the VH locus, at least 600 kb from J H ( Table 4) .
Of the 33 VFb-JH rearrangements sequenced, 3 retained an open-reading frame (ORF). In the other 30 rearrangements, the ORF was lost because of stop or missense codons distributed throughout the length of the VH gene andor internal deletions within the VH gene. For example, case no. 28 was found to have a VH2-DLR4-JH6b rearrangement, with a deletion of 87 bp. This deletion commenced at the VH intron-exon boundary and included the whole intron with the exception of the last base; the remaindex of the VH gene was intact but showed deviation from the most similar germline vH2 gene. Deviation from known germline VH genes was detected in 29 of 33 (88%) VH-DH-JH rearrangements sequenced, the percentage deviation ranged from 0.3% to 9.7% (mean, 2.3%). In all cases, whether OW+ or OW-, the point mutations were not clustered within the CDR regions but were distributed along the length of the VH gene^.'^,^^ Analysis of D H segment usage showed that the DXP and DLR families represented 29% and 24% of rearrangements, respectively. DH-DH fusions were present in 8 of 41 (19%) sequences, and no DH segment was identifiable in 5 of 41 (12%). Analysis of J H segment usage showed that 53%, 25%, and 15% of rearrangements used JH4, JH6 and JH5, respectively, with underrepresentation of J H 1 , 2 , and 3. There were no mutations in the J H segments. Of 41 BCP-ALL sequences, 5 (12%) had no N regions or a P nucleotide at the DHJH junction, but all cases showed N regions at the VHDH junction. Terminal deoxynucleotidyl transferase was expressed in all cases.
DISCUSSION
The impetus to this study was that in BCP-ALL some rearranged IGH alleles and, indeed, up to 20% of cases fail
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HEIGHT ET AL totally to amplify with FRIWJH PCR primers. Unlike the non-Hodgkin lymphomas, in which translocations to the IGH locus are common, such translocations are rare in BCP-ALL and cannot be implicated in the high failure rate. Therefore, we sought to determine the causes of FRIII PCR failure in this disease by comparing the results obtained by DNA blot (which allowed the number of rearranged IGH alleles to be estimated) and those obtained by PCR methods using VH leader, FRIII and D,-specific primers. Second, we sought to determine whether total absence of signal with FRIII primers correlated with a specific subgroup of BCP-ALL.
Of the 37 cases of BCP-ALL, 6 (16.2%) were FRIII PCRnegative. These cases showed 11 rearranged IGH alleles by DNA blot, of which 5 could be amplified with a consensus DH primer and, therefore, represented DH-JH rearrangements. The failure to amplify the remaining 6 alleles probably represented a failure of the consensus DH primer; this primer was designed to amplify the DH segments used in about 60% of rearranged IGH alleles in BCP-ALL.25 However, the failure of the VH leader primers to amplify successfully any of the rearranged IGH alleles in the absence of cytogenetically detectable translocations and the retention of an intact VH6 gene in all cases makes it likely that most, if not all, of these rearrangements represented DHJH rearrangements.
Because VHDHJH recombination is developmentally regulated, this implies a developmental arrest of the neoplastic B-cell clones before the activation of the full VHDHJH recombinase. Moreover, because VHDH and DHJH recombinations occur very early in B-cell differentiation, it might be anticipated that these cases might show a less differentiated immunophenotype and a consistent cytogenetic abnormality. This was not the case, although 3 of the 5 cases successfully karyotyped showed abnormalities of 12p. Whether the subgroup thus defined was associated with a particular therapeutic outcome could not be determined from this small sample. It was noteworthy that all 6 retained germline p16KDKN2 gene^.*^,'^ Otherwise, of the 14 other cases in which a discrepancy between DNA blot and FRIII PCR was observed, the use of the 6 VH leader-specific primers increased the detection of IGH rearrangements from 55% observed with FRIII PCR to 90% in this group. This may be of importance in monitoring BCP-ALL for residual disease in which more than one marker may be necessary to follow the neoplastic clone with confidence. Sequencing of the rearranged VH genes that failed to amplify with the FRIII primers showed that this was due in all cases to the loss of the 3' portion of the primer site, presumably as a consequence of exonuclease activity at the time of recombination.' It was not possible to design a further more 5' consensus FRIII primer to overcome this phenomenon.
Sequencing of 33 of the rearranged VH genes showed a number of other interesting features. First, mutations (or strictly deviations from the known germline VH sequences) and deletions of the rearranged VH genes were detected in 29 (88%) cases. The mutations were not clustered in the CDR regions but were found throughout the VH genes. Only 4 sequences were completely identical to previously sequenced VH genes. Because the corresponding germline VH genes were not sequenced, we cannot exclude the possibility that some of the rearranged VH sequences might represent previously undescribed polymorphisms. However. VH sequencing data from normal individuals have indicated that such polymorphisms are uncommon.' Furthermore, it was unlikely that these rearrangements represented the involvement of VH "orphan genes" on chromosomes 15 and 16, because this would have required translocation to the JH segments of the IGH locus at 14q32.3; no such translocations were observed. Given that the mean deviation from known germline sequences was 2.3%, this deviation could also not be explained by Taq DNA polymerase incorporation error alone. Moreover, several clones from different PCR reactions were sequenced in each case with identical results.
Similar mutations have been previously reported in a series of 9 cases of BCP-ALL studied by FRI PCR." The frequency of nucleotide changes within the VH genes varied from 0.2% to 2.4%, and, as reported here, the mutations were not clustered to the CDRs but were scattered throughout the length of the VH genes. In contrast, it should be noted that 6 rearranged VH genes (isolated by genomic phage cloning from 2 patients with multiple JH rearrangements) showed no evidence of somatic mutation." The reasons for these differences are not clear. However, the combination of our data on 33 rearranged VH genes along with those of Kitchingman" and the observation that somatic mutation can occur in virally transformed mouse pre-B cells'' strongly suggests that somatic mutation can occur in at least some BCPs before the expression of surface Ig. Whether the mechanism is identical to that which occurs in more mature B cells after exposure to antigen and results in affinity maturation of antibody" is not known. The lack of clustering of mutations to the CDRs in BCPs might be anticipated because of the lack of Ig expression.
A second feature of interest was that only 3 of 33 (9%) VH-DH-JH genes sequenced in this study retained an ORF, in part because of the presence of both the mutations and deletions resulting in stop or missense codons distributed throughout the VH gene. This percentage of rearrangements with an O W would be expected of a population of B cells unselected by antigen. However, a functional Ig molecule is necessary for the later stages of B-cell maturation7; therefore, these data indicate that most BCP-ALL represent the neoplastic transformation of BCPs destined to die in the bone marrow. This is in contrast to the observations of Steenbergen et aP7 who, on the basis of analysis of the CDRIII product alone, showed maintenance of an ORF in 17 of 68 (25%) cases. Here, however, by the use of VH leader primers, it was possible to show other causes for the loss of the ORF in rearranged VH genes. The transformation of BCPs destined to undergo apoptosis as a result of failing to complete inframe VH-DH-JH recombination might explain the high frequency of TCR gene rearrangements in these cases, arising through persistent expression of recombinase.
Finally, as regards VH gene usage, there was no evidence in this study for preferential usage of JH-proximal VH genes. Instead, VH genes were scattered throughout the IGH locus, and 36% of rearrangements occurred with VH segments more than 500 kb distal of JH. As with other studies on normal Bcell populations VH3-23 (which constitutes 26% of the 500 rearranged VH3 genes in the rearranged database3) was also The causes for the preferential selection of the 5~4 and the J H~ segments are unknown. Five sequences were identified that lacked N regions at the DH-JH junction, which is supposedly a feature of "primitive" rearrangements; and, although one sequence was isolated from a 4-year-old, the remainder were found in adults with Ph' leukemia, suggesting that in these leukemias the rearrangement mechanism retains some features of that which occurs in very early fetal B cells. However, all cases showed N regions at the VHDH junction.
Thirteen cases of BCP-ALL and biphenotypic acute leukemias with t(9;22)(q34;qll) showed 23 rearranged IGH alleles; all 23 were successfully amplified with either the FRIT1 andor the VH leader primers, thus implying full VHDHJH recombination. This was confirmed by DNA sequencing of 21 rearranged VH genes. Therefore, these data indicate that the acquisition of the t(9;22)(q34;ql l), which is thought to occur either very early in B-cell differentiation or at the level of the multipotent hemopoietic stem cell, nevertheless, did not influence the activity of the VHDHJH recombinase. This is in contrast to the BCP-ALL arrested at the stage of D H J H rearrangement.
Furthermore, that VHDHJH recombination may continue in BCP-ALL with t(9;22)(q34;qll) was suggested by the presence of 3 cases in which additional VH rearrangements unanticipated from Southern blot were detected by VH leader PCR. These additional subclones represented "new" VH rearrangements rather than VH-VH replacements in which the D H -J H segment usually remains intact. In 1 case, the additional subclones were detected after serial passage of the BCP-ALL in SCID mice. Such additional subclones were not detected in 21 other cases lacking the t(9;22)(q34;qll) and have not been observed in other t(9;22)-negative cases passaged in SCID mice. These data may indicate that in some cases of BCP-ALL the t(9; 22)(q34;ql l) occurs before the activation of the VHDHJH recombinase; the persistent expression of the VHDHJH recombinase acting on the germline IGH genes of the leukemic "stem cell" population may then account for the generation of new VHDHJH rearrangements during the course of the disease.
